EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy

Tongyu Liu, Yun Zhou, Lijun Chen, Qinying Liu, Dan Hu, Rongfang Huang, Haizhou Ji, Yuzhen Lin, Yang Sun

Frontiers in Bioscience-Landmark · 19.08.2024 · 29 (8)

DOI: 10.31083/j.fbl2908289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 19.08.2024. Verfasst von Tongyu Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, 350014 Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Polypyrimidine Tract-Binding Protein, Uterine Cervical Neoplasms, Autophagy, Apoptosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Medical Innovation Proiect of Fuiian Province, Natural Science Foundation of Fujian Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cervical cancer is the most common gynecological malignancy in the world and seriously threatens to women’s lives and health. Polypyrimidine tract binding protein 1 (PTBP1), as an important splicing factor, has been identified as a proto-oncogene in several cancers, but its role and mechanism in cervical cancer remain poorly understood. Thus, our aim is to explore the impact of PTBP1 on proliferation, migration, apoptosis of cervical cancer cells, and its underlying mechanisms.

Methods

The biological functions in cervical cancer cells were determined using small interfering RNA (siRNA), agonist, Cell Counting Kit-8 (CCK-8), transwell, migration test, western blot, real-time-PCR, immunohistochemistry and immunofluorescence, respectively.

Results

The results indicated that PTBP1 was highly expressed in cervical cancer patients and cervical cancer cell lines compared to the normal group. Moreover, PTBP1 silencing significantly inhibited cell proliferation, and migration in both HeLa and SiHa cells. The PTBP1 silencing also induced mitochondrial apoptosis through upregulating Bax and mitochondrial apoptotic protein Cytochrome C, and downregulating B-Cell Leukemia/Lymphoma 2 (Bcl2) protein. Additionally, PTBP1 silencing induced autophagy by downregulating Sequestosome I (p62) and upregulating the ratio of Light chain 3-Ⅱ/Light chain 3-Ⅰ (LC3-Ⅱ/LC3-Ⅰ). Mechanistically, we found that the Phosphoinositide 3-kinase (PI3K) agonist reversed the changes induced by PTBP1 silencing.

Conclusions

Overall, PTBP1 silencing can induce cervical cancer cells apoptosis mainly through PI3K/AKT pathway and protective autophagy. This study provides preliminary evidence for PTBP1 as a therapeutic target or prognostic marker for cervical cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polypyrimidine Tract-Binding ProteinUterine Cervical NeoplasmsAutophagyApoptosisProto-Oncogene Proteins c-aktHeterogeneous-Nuclear RibonucleoproteinsProto-Oncogene MasSignal TransductionPhosphatidylinositol 3-KinasesCell ProliferationHumansFemaleCell Line, TumorCell MovementHeLa CellsGene SilencingGene Expression Regulation, NeoplasticRNA, Small Interfering

Stichwörter der Autor:innen

PI3K/AKT pathwayPTBP1apoptosisautophagycervical cancer

Substanzen

Polypyrimidine Tract-Binding ProteinPTBP1 protein, humanProto-Oncogene Proteins c-aktHeterogeneous-Nuclear RibonucleoproteinsMAS1 protein, humanProto-Oncogene MasPhosphatidylinositol 3-KinasesRNA, Small Interfering

Autor:innen und Institutionen

  • Department of Gynecology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, 350014 Fuzhou, Fujian, China.
  • Department of Obstetrics and Gynecology, Shengli Clinical Medical College of Fujian Medical University and Fujian Provincial Hospital, 350001 Fuzhou, Fujian, China.
  • Fujian Provincial Key Laboratory of Tumor Biotherapy, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, 350014 Fuzhou, Fujian, China.
  • Department of Pathology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, 350000 Fuzhou, Fujian, China.

Förderung

  • National Natural Science Foundation of China
  • Medical Innovation Proiect of Fuiian Province
  • Natural Science Foundation of Fujian Province

Zitieren

APA

Liu, T., Zhou, Y., Chen, L., Liu, Q., Hu, D., Huang, R., Ji, H., Lin, Y., & Sun, Y. (2024). Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy. Frontiers in Bioscience-Landmark, 29(8). https://doi.org/10.31083/j.fbl2908289

Vancouver

Liu T, Zhou Y, Chen L, Liu Q, Hu D, Huang R, et al. Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy. Frontiers in Bioscience-Landmark. 2024;29(8). doi:10.31083/j.fbl2908289

BibTeX
@article{Liu2024,
  author = {Liu, Tongyu and Zhou, Yun and Chen, Lijun and Liu, Qinying and Hu, Dan and Huang, Rongfang and Ji, Haizhou and Lin, Yuzhen and Sun, Yang},
  title = {Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  volume = {29},
  number = {8},
  doi = {10.31083/j.fbl2908289}
}
Kostenlos starten →